SCHEMBL13428446

SCHEMBL13428446

CC(C)OCCCNc1ncc(CO)cc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.39
RAB9A P51151 3/20 0.39
GAA P10253 2/20 0.39
NPC1 O15118 2/20 0.39
MCHR1 Q99705 1/20 0.39
MAPT P10636 5/20 0.39
MAPK1 P28482 3/20 0.39
CASP3 P42574 1/20 0.39
BLM P54132 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ALDH1A1 P00352 5/20 0.39
HIF1A Q16665 1/20 0.39
LMNA P02545 4/20 0.38
TSHR P16473 3/20 0.38
HTT P42858 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13428492 0.93 MCHR1 (0.36) KDM4ERAB9AGAANPC1MCHR1
SCHEMBL8179188 0.85 KDM4E (0.39) KDM4ERAB9AGAANPC1MCHR1
SCHEMBL3831496 0.80 KMT2A (0.40) KDM4ERAB9ANPC1MAPK1TDP1
SCHEMBL13428507 0.80 MAPT (0.41) KDM4ERAB9AGAANPC1MCHR1
SCHEMBL8173678 0.80 PIK3CD (0.44) KDM4ERAB9ANPC1ALDH1A1GBA1
SCHEMBL8186173 0.77 CSNK2A2 (0.35) KDM4ERAB9AGAANPC1MCHR1
SCHEMBL13428420 0.77 TP53 (0.41) KDM4EMAPTALDH1A1TP53KMT2A
SCHEMBL13428784 0.76 MAPT (0.43) RAB9AMAPTMAPK1ALDH1A1TSHR
SCHEMBL13428579 0.76 ALDH1A1 (0.42) KDM4ERAB9AGAANPC1MCHR1
SCHEMBL3221498 0.75 PIK3CD (0.48) KDM4ERAB9AGAANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100069388-A1 N-HYDROXYACRYLAMIDE COMPOUNDS ASTELLAS PHARMA INC. (JP) 2010-03-18 US disclosed
US-20100069388-A1 N-HYDROXYACRYLAMIDE COMPOUNDS ASTELLAS PHARMA INC. (JP) 2010-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069388-A1 N-HYDROXYACRYLAMIDE COMPOUNDS HDAC1, HDAC11, HDAC2 KDM4E 253/4885RAB9A 4190/4885GAA 3435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.